logo_ProQR-150x150.png
ProQR spins out Amylon Therapeutics as a privately-held company focused on central nervous system (CNS) therapeutics
12 sept. 2017 07h00 HE | ProQR Therapeutics N.V.
Key updates ProQR spins out CNS-focused company, Amylon Therapeutics, with seed funding from a group of institutional and private investors.As part of the transaction, ProQR has granted an exclusive...